Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (391-400 of 520) with videos related to

Pageof 52
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancerB F El-Rayes, M M Zalupski, A F Shields, et al.
Oncology|October 18, 2017
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)Jordan D Berlin, Yang Feng, Paul Catalano, et al.
Cancer Metastasis Reviews|April 20, 2021
Gastrointestinal stromal tumor: a review of current and emerging therapiesBayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, et al.
Signal Transduction and Targeted Therapy|November 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challengesKhalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, et al.
Investigational New Drugs|July 22, 2005
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancerBasil F El-Rayes, Mark M Zalupski, Anthony F Shields, et al.
The Annals of Thoracic Surgery|November 28, 2001
Systemic steroid pretreatment improves cerebral protection after circulatory arrestD Shum-Tim, C I Tchervenkov, A M Jamal, et al.
Nature|August 27, 2010
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory responsePing Rao, Mathew S Hayden, Meixiao Long, et al.
Oncotarget|November 16, 2017
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migrationAsfar S Azmi, Yiwei Li, Irfana Muqbil, et al.
Investigational New Drugs|March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancersT Ciuleanu, M Diculescu, N M Hoepffner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyureaP A Philip, V L Souliotis, A L Harris, et al.
Pageof 52

Showing results (391-400 of 520) with videos related to

Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancerB F El-Rayes, M M Zalupski, A F Shields, et al.
Oncology|October 18, 2017
An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)Jordan D Berlin, Yang Feng, Paul Catalano, et al.
Cancer Metastasis Reviews|April 20, 2021
Gastrointestinal stromal tumor: a review of current and emerging therapiesBayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, et al.
Signal Transduction and Targeted Therapy|November 27, 2025
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challengesKhalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, et al.
Investigational New Drugs|July 22, 2005
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancerBasil F El-Rayes, Mark M Zalupski, Anthony F Shields, et al.
The Annals of Thoracic Surgery|November 28, 2001
Systemic steroid pretreatment improves cerebral protection after circulatory arrestD Shum-Tim, C I Tchervenkov, A M Jamal, et al.
Nature|August 27, 2010
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory responsePing Rao, Mathew S Hayden, Meixiao Long, et al.
Oncotarget|November 16, 2017
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migrationAsfar S Azmi, Yiwei Li, Irfana Muqbil, et al.
Investigational New Drugs|March 17, 2007
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancersT Ciuleanu, M Diculescu, N M Hoepffner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyureaP A Philip, V L Souliotis, A L Harris, et al.
Pageof 52